Andrew Grieve is the CEO of Zenabis and he joined Business of Cannabis to talk about their agreement to grow Tantalus Labs genetics on contract as well as their stock offering to current shareholders – which has been the topic of conversation among those that follow publicly traded cannabis companies.
Business of Cannabis: New York 2025 arrived at a crucial moment not just for the local cannabis industry, but for...
President Donald Trump has called on Senate Republicans to invoke the so-called ‘nuclear option’ to break the month-long government shutdown,...
Business of Cannabis: New York 2025 arrived at a crucial moment not just for the local cannabis industry, but for...
President Donald Trump has called on Senate Republicans to invoke the so-called ‘nuclear option’ to break the month-long government shutdown,...
As New Yorkers prepare to head to the polls to vote for their new Mayor tomorrow (Tuesday, November 04), the...
Next Thursday, 6 November 2025, Business of Cannabis: New York returns to The Wythe Hotel, Williamsburg, uniting more than 300...
Oregon-based edibles company Grön has weighed in on the ongoing controversy surrounding New York’s so-called ‘rent-a-licence’ scandal. The dispute follows...
Hexo Corp has reported third quarter losses of C$129.7m as shareholders vote to approve the company's acquisition by Tilray. Last...
HELLENIC Dynamics became the first pureplay cannabis cultivator to list on the London Stock Exchange (LSE) last week after nearly...
☀️ SUNLIGHT ON SUNGROWN ‘Building in the open’ with Tantalus’s Dan Sutton Dan Sutton, founder and CEO of B.C.-based Tantalus...
Miguel Martin, CEO of Aurora, tells Business Insider that the company is pivoting — back to medical cannabis. The company’s...
Dan Sutton, the BC-based CEO and founder of craft cultivators Tantalus Labs, is a man of his word: After sharing...
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
